awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42713576-0C1BCA1F-E39C-4F2C-9A62-B4B08ED1396D
Q42713576-0C1BCA1F-E39C-4F2C-9A62-B4B08ED1396D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42713576-0C1BCA1F-E39C-4F2C-9A62-B4B08ED1396D
Activity-based kinase profiling of approved tyrosine kinase inhibitors.
P2860
Q42713576-0C1BCA1F-E39C-4F2C-9A62-B4B08ED1396D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42713576-0C1BCA1F-E39C-4F2C-9A62-B4B08ED1396D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7163b248ef3ffcc29c1bc58b9a4591891fffef8c
P2860
FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets.